Alkermes (ALKS) Other Non-Current Liabilities (2011 - 2026)
Alkermes (ALKS) reported Other Non-Current Liabilities of $68.0 million for Q1 2026, up 15.63% year-over-year from $58.9 million in Q1 2025, and up 11.54% quarter-over-quarter from $61.0 million in Q4 2025.
Alkermes (ALKS) Other Non-Current Liabilities (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has 16 years of Other Non-Current Liabilities data on file, last reported at $68.0 million in Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $68.0 million, up 15.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $68.0 million (up 15.63% YoY), and the FY2025 annual result was $61.0 million, up 8.91% from the prior year.
- Other Non-Current Liabilities improved to $68.0 million in Q1 2026 per ALKS's latest filing, from $61.0 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $68.0 million in Q1 2026 and troughed at $42.4 million in Q4 2022.
- A 5-year average of $51.8 million and a median of $49.9 million in 2023 frame the typical range for Other Non-Current Liabilities.
- On a YoY basis, Other Non-Current Liabilities climbed as much as 33.43% in 2022 and fell as far as 2.9% in 2022.
- A 5-year view of Other Non-Current Liabilities shows it stood at $42.4 million in 2022, then increased by 17.68% to $49.9 million in 2023, then increased by 12.31% to $56.0 million in 2024, then increased by 8.91% to $61.0 million in 2025, then gained by 11.54% to $68.0 million in 2026.
- Business Quant data shows ALKS's Other Non-Current Liabilities at $68.0 million in Q1 2026, $61.0 million in Q4 2025, and $56.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.05 Mn |
| Dec 31, 2025 | 61.01 Mn |
| Sep 30, 2025 | 56.75 Mn |
| Jun 30, 2025 | 56.05 Mn |
| Mar 31, 2025 | 58.85 Mn |
| Dec 31, 2024 | 56.02 Mn |
| Sep 30, 2024 | 52.63 Mn |
| Jun 30, 2024 | 48.29 Mn |
| Mar 31, 2024 | 48.96 Mn |
| Dec 31, 2023 | 49.88 Mn |
| Sep 30, 2023 | 53.62 Mn |
| Jun 30, 2023 | 48.22 Mn |
| Mar 31, 2023 | 48.49 Mn |
| Dec 31, 2022 | 42.38 Mn |
| Sep 30, 2022 | 42.86 Mn |
| Jun 30, 2022 | 45.21 Mn |
| Mar 31, 2022 | 43.91 Mn |
| Dec 31, 2021 | 43.65 Mn |
| Sep 30, 2021 | 32.12 Mn |
| Jun 30, 2021 | 36.32 Mn |